Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial
Abroad (travel likely)RecruitingPHASE2
Conditions
Clonal Cytopenia of Undetermined Significance · CCUS Clonal Cytopenia of Undetermined Significance
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Giulia Petrone, M.D.)
Study leads
Giulia Petrone, M.D.
Principal Investigator
Washington University School of Medicine